The utility of plasma circulating cell-free messenger RNA as a biomarker of glioma: a pilot study.

We identified significant differential expression of genes involved in cancer inflammation and immunity crosstalk among patients with different glioma grades, and there was positive correlation between their transcriptomic profile in plasma and tumour samples, and with TCGA glioma-derived RNA.